Empirical-Null Calibration Challenges Comparative CNS Safety Signals for Androgen-Receptor Pathway Inhibitors: A FAERS Re-Analysis. [PDF]
Pharmaceuticals (Basel)İnkaya A, Güngör HS.
europepmc +1 more source
Mineralocorticoid Receptor Antagonists for Liver Fibrosis: Potential Mechanisms and Research Progress. [PDF]
J Clin Transl HepatolZheng H, Feng Y.
europepmc +1 more source
Targeting the Androgen Receptor Pathway in Prostate Cancer: A PROTrACted Struggle. [PDF]
Clin Cancer ResNyquist MD, Nelson PS.
europepmc +1 more source
Distinguishing direct androgenic signaling from local aromatization in the lateral septum. [PDF]
Proc Natl Acad Sci U S AHuang D, Dong J.
europepmc +1 more source
Androgen-Modulating Drugs and Severe Complications After ST-Elevation Myocardial Infarction.
JAMA Netw OpenColldén H +5 more
europepmc +1 more source
The role of lysophosphatidic acid metabolism in castration-resistant prostate cancer progression. [PDF]
Front OncolFeng J, Liu J, He Y.
europepmc +1 more source
Treatment of Hot Flashes in Men With Prostate Cancer Undergoing Androgen Deprivation Therapy. [PDF]
ProstateSchaldemose EL +3 more
europepmc +1 more source
Progress in the Application of Exosomes in Androgenetic Alopecia: Focusing on Molecular Mechanisms. [PDF]
Int J NanomedicineChen Y +6 more
europepmc +1 more source
Differences in adverse drug reactions between GnRH antagonists and agonists in the treatment of prostate cancer: a retrospective analysis using real-world data. [PDF]
Front PharmacolLuo Y +8 more
europepmc +1 more source
Selective CB<sub>2</sub> Agonist <i>JWH-133</i> Suppresses Viability and Migration-Related Responses in Prostate Cancer Cells. [PDF]
Pharmaceuticals (Basel)Özcan SS +5 more
europepmc +1 more source